THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Judith James and A. Farris.
Connection Strength

3.081
  1. Peptidoglycan from Bacillus anthracis Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3. Immunohorizons. 2024 Mar 01; 8(3):269-280.
    View in: PubMed
    Score: 0.234
  2. Autoantibodies identify primary Sj?gren's syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B. Ann Rheum Dis. 2023 May 05.
    View in: PubMed
    Score: 0.221
  3. Peptidoglycan from Bacillus anthracis Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3. bioRxiv. 2023 Apr 03.
    View in: PubMed
    Score: 0.220
  4. Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes. PLoS One. 2020; 15(4):e0230782.
    View in: PubMed
    Score: 0.179
  5. Bacillus anthracis Edema Toxin Inhibits Efferocytosis in Human Macrophages and Alters Efferocytic Receptor Signaling. Int J Mol Sci. 2019 Mar 07; 20(5).
    View in: PubMed
    Score: 0.166
  6. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients. Clin Vaccine Immunol. 2017 Nov; 24(11).
    View in: PubMed
    Score: 0.151
  7. Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated. Vaccine. 2017 06 08; 35(26):3416-3422.
    View in: PubMed
    Score: 0.146
  8. Unique Inflammatory Mediators and Specific IgE Levels Distinguish Local from Systemic Reactions after Anthrax Vaccine Adsorbed Vaccination. Clin Vaccine Immunol. 2016 08; 23(8):664-71.
    View in: PubMed
    Score: 0.139
  9. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura. PLoS One. 2015; 10(2):e0117614.
    View in: PubMed
    Score: 0.125
  10. Protective antigen-specific memory B cells persist years after anthrax vaccination and correlate with humoral immunity. Toxins (Basel). 2014 Aug 13; 6(8):2424-31.
    View in: PubMed
    Score: 0.121
  11. Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization. Vaccine. 2013 Apr 03; 31(14):1856-63.
    View in: PubMed
    Score: 0.109
  12. MHC class II and non-MHC class II genes differentially influence humoral immunity to Bacillus anthracis lethal factor and protective antigen. Toxins (Basel). 2012 Dec; 4(12):1451-67.
    View in: PubMed
    Score: 0.108
  13. Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization. Vaccine. 2012 Jun 13; 30(28):4276-83.
    View in: PubMed
    Score: 0.102
  14. Anthrax lethal toxin-induced gene expression changes in mouse lung. Toxins (Basel). 2011 09; 3(9):1111-30.
    View in: PubMed
    Score: 0.099
  15. Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity. Vaccine. 2011 May 09; 29(20):3670-8.
    View in: PubMed
    Score: 0.096
  16. Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge. J Infect Dis. 2010 Jul 15; 202(2):251-60.
    View in: PubMed
    Score: 0.091
  17. The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes. Infect Immun. 2009 Nov; 77(11):4714-23.
    View in: PubMed
    Score: 0.086
  18. Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies. Infect Immun. 2009 Jan; 77(1):162-9.
    View in: PubMed
    Score: 0.081
  19. Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland. bioRxiv. 2023 Oct 06.
    View in: PubMed
    Score: 0.057
  20. Author Correction: Genome-wide association study identifies Sj?gren's risk loci with functional implications in immune and glandular cells. Nat Commun. 2023 Feb 03; 14(1):598.
    View in: PubMed
    Score: 0.054
  21. Dysregulated long non-coding RNA in Sjögren's disease impacts both interferon and adaptive immune responses. RMD Open. 2022 Nov; 8(2).
    View in: PubMed
    Score: 0.053
  22. Author Correction: Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells. Nat Commun. 2022 Oct 31; 13(1):6519.
    View in: PubMed
    Score: 0.053
  23. Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells. Nat Commun. 2022 07 27; 13(1):4287.
    View in: PubMed
    Score: 0.052
  24. And Yet It Moves: Oxidation of the Nuclear Autoantigen La/SS-B Is the Driving Force for Nucleo-Cytoplasmic Shuttling. Int J Mol Sci. 2021 Sep 08; 22(18).
    View in: PubMed
    Score: 0.049
  25. Two Be or Not Two Be: The Nuclear Autoantigen La/SS-B Is Able to Form Dimers and Oligomers in a Redox Dependent Manner. Int J Mol Sci. 2021 Mar 25; 22(7).
    View in: PubMed
    Score: 0.048
  26. T Cell Mediated Conversion of a Non-Anti-La Reactive B Cell to an Autoreactive Anti-La B Cell by Somatic Hypermutation. Int J Mol Sci. 2021 Jan 26; 22(3).
    View in: PubMed
    Score: 0.047
  27. Evidence of Alternative Modes of B Cell Activation Involving Acquired Fab Regions of N-Glycosylation in Antibody-Secreting Cells Infiltrating the Labial Salivary Glands of Patients With Sjögren's Syndrome. Arthritis Rheumatol. 2018 07; 70(7):1102-1113.
    View in: PubMed
    Score: 0.039
  28. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest. 1997 Dec 15; 100(12):3019-26.
    View in: PubMed
    Score: 0.038
  29. Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. PLoS Genet. 2017 Jun; 13(6):e1006820.
    View in: PubMed
    Score: 0.037
  30. Antibody-secreting cell specificity in labial salivary glands reflects the clinical presentation and serology in patients with Sjögren's syndrome. Arthritis Rheumatol. 2014 Dec; 66(12):3445-56.
    View in: PubMed
    Score: 0.031
  31. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet. 2013 Nov; 45(11):1284-92.
    View in: PubMed
    Score: 0.029
  32. Autoimmunity as a result of escape from RNA surveillance. J Immunol. 2006 Aug 01; 177(3):1698-707.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES